<DOC>
	<DOC>NCT00473980</DOC>
	<brief_summary>The study is designed to evaluate effects of NSAIDs on immune activity inside and close to tumor tissue in patients with colorectal cancer.</brief_summary>
	<brief_title>Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients</brief_title>
	<detailed_description>Study and control patients are randomized to receive preoperative treatment with indomethacin or celecoxib compared to sham treatment.Tumor biopsies are taken at operation and used for analyses of tumor immunity and gene expression.</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Colon carcinoma scheduled for curative operation Diabetes, steroid medication, liver and kidney impairment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>MHC</keyword>
	<keyword>CTLs</keyword>
	<keyword>Colon carcinoma</keyword>
	<keyword>NSAID</keyword>
	<keyword>Survival</keyword>
</DOC>